Covid-19: FDA puts Moderna’s paediatric application on hold to investigate side effects
The US emergency use authorisation of Moderna’s coronavirus vaccine in people aged 12-17 will be delayed, the company has been told by the Food and Drug Administration (FDA), while the regulator…
